GLMN — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL27357734	0.60	4/20
SCHEMBL27356030	0.59	4/20
SCHEMBL27357738	0.58	4/20
SCHEMBL27355985	0.81	3/20
SCHEMBL30685056	0.81	3/20
SCHEMBL27357736	0.79	3/20
SCHEMBL30684953	0.79	3/20
SCHEMBL30684983	0.79	3/20
SCHEMBL27356154	0.79	3/20
SCHEMBL30685225	0.79	3/20
SCHEMBL27356042	0.77	3/20
SCHEMBL30684999	0.77	3/20
SCHEMBL30685102	0.77	3/20
SCHEMBL30685103	0.77	3/20
SCHEMBL30685294	0.77	3/20
SCHEMBL31732567	0.77	3/20
SCHEMBL27356211	0.76	3/20
SCHEMBL27356164	0.75	3/20
SCHEMBL30685077	0.75	3/20
SCHEMBL27356139	0.73	3/20

Clinical trials — most relevant to GLMN by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)	PHASE2/PHASE3	COMPLETED
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients	PHASE2	ENROLLING_BY_INVITATION
A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)	PHASE2	COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)	PHASE2	COMPLETED
Diabetic Retinopathy Sulodexide Study	PHASE2	COMPLETED
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy	PHASE1/PHASE2	RECRUITING
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans	PHASE1	COMPLETED
Study of LGW16-03 To Identify Nerves	PHASE1	RECRUITING
Perioperative Plasma Levels of Glycocalyx Markers in Colon Surgery.	nan	UNKNOWN
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China	nan	ENROLLING_BY_INVITATION
Efficacy of Physical Exercise on Glucose Control in People With Prediabetes (GLYCEX) - Phase II	nan	UNKNOWN
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)	nan	COMPLETED
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV	nan	COMPLETED
Micro and Macro Circulation in Sepsis	nan	COMPLETED
Effect of Dietary Glycemic Index on Beta-cell Function	nan	COMPLETED
Glucose-dependent Asprosin Dynamics	nan	COMPLETED
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism	nan	NOT_YET_RECRUITING
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients	nan	COMPLETED
Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome	nan	ACTIVE_NOT_RECRUITING
Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)	nan	UNKNOWN
Early Gestational Diabetes Screening in the Gravid Obese Woman	nan	COMPLETED
Clinical Trial Readiness for the Dystroglycanopathies	nan	RECRUITING
Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in Patients With Extreme Glucose Metabolism Phenotypes	nan	NOT_YET_RECRUITING
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus	nan	NOT_YET_RECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages	nan	COMPLETED
The Underlying Mechanisms Regarding the Effect of Glucagon on the Kidneys Will be Investigated in Healthy Males.	nan	RECRUITING
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing	nan	COMPLETED
High-fat Overfeeding, Hepatokines and Appetite Regulation	nan	COMPLETED
Genetic Causes of Gestational Diabetes in the Emirati Population	nan	UNKNOWN
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a GLMN binder may also engage these)

Protein	Name	Similarity
Q8BZM1	—	1.000	Q8BZM1 →
Q640K1	—	0.998	Q640K1 →
Q5ZLS8	—	0.996	Q5ZLS8 →
Q5FWU8	—	0.996	Q5FWU8 →
Q3UHQ6	—	0.995	Q3UHQ6 →
Q8H0T4	—	0.995	Q8H0T4 →
Q96N23	—	0.995	Q96N23 →
UTP20	Small subunit processome component 20 homolog	0.994	landscape →
Q6ZQK0	—	0.994	Q6ZQK0 →
P97313	—	0.994	P97313 →
Q8K1K4	—	0.993	Q8K1K4 →
FANCI	Fanconi anemia group I protein	0.993	landscape →
RIF1	Telomere-associated protein RIF1	0.993	landscape →
Q8C6S9	—	0.993	Q8C6S9 →
Q10222	—	0.992	Q10222 →
Q9H579	—	0.992	Q9H579 →
E1BGH8	—	0.992	E1BGH8 →
Q6TNU3	—	0.992	Q6TNU3 →
Q6GPP1	—	0.992	Q6GPP1 →
Q9FIN7	—	0.992	Q9FIN7 →
Q6ZQ18	—	0.992	Q6ZQ18 →
BCL2A1	Bcl-2-related protein A1	0.992	landscape →
Q294E0	—	0.992	Q294E0 →
E1C2Z0	—	0.992	E1C2Z0 →
Q68Y81	—	0.992	Q68Y81 →
Q8R0G9	—	0.991	Q8R0G9 →
Q2TAA8	—	0.991	Q2TAA8 →
Q6IV68	—	0.991	Q6IV68 →
Q8QGX4	—	0.991	Q8QGX4 →
A0JMA8	—	0.991	A0JMA8 →